Fecal Microbial transplant Capsules
Combination Product3 pills per day for 3 consecutive days with placebo comparatator
NCT Number: NCT07265817
The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.
Trial opening soon.
Get Notified19 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 pills per day for 3 consecutive days with placebo comparatator
The same amount and shape capsules
Time frame: 1 year
Kyungpook National University Hospital
Other
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms: Randomized Double Blinded Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07685132
Antimicrobial Resistance (AMR), Carbapenem-Resistant Enterobacteriaceae Colonization
Buenos Aires, Buenos Aires F.D., Argentina
View Trial DetailsNCT05594901
Carbapenem-Resistant Enterobacteriaceae Colonization, Liver Transplantation
São Paulo, Brazil
View Trial Details